IRIS Accounts Production v23.3.1.45 05737737 Board of Directors 1.4.22 31.3.23 31.3.23 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure057377372022-03-31057377372023-03-31057377372022-04-012023-03-31057377372021-03-31057377372021-04-012022-03-31057377372022-03-3105737737ns16:EnglandWales2022-04-012023-03-3105737737ns15:PoundSterling2022-04-012023-03-3105737737ns11:Director12022-04-012023-03-3105737737ns11:PrivateLimitedCompanyLtd2022-04-012023-03-3105737737ns11:SmallEntities2022-04-012023-03-3105737737ns11:AuditExempt-NoAccountantsReport2022-04-012023-03-3105737737ns11:SmallCompaniesRegimeForDirectorsReport2022-04-012023-03-3105737737ns11:SmallCompaniesRegimeForAccounts2022-04-012023-03-3105737737ns11:FullAccounts2022-04-012023-03-310573773712022-04-012023-03-3105737737ns11:Director22022-04-012023-03-3105737737ns11:CompanySecretary12022-04-012023-03-3105737737ns11:RegisteredOffice2022-04-012023-03-3105737737ns6:CurrentFinancialInstruments2023-03-3105737737ns6:CurrentFinancialInstruments2022-03-3105737737ns6:Non-currentFinancialInstruments2023-03-3105737737ns6:Non-currentFinancialInstruments2022-03-3105737737ns6:ShareCapital2023-03-3105737737ns6:ShareCapital2022-03-3105737737ns6:RetainedEarningsAccumulatedLosses2023-03-3105737737ns6:RetainedEarningsAccumulatedLosses2022-03-3105737737ns6:NetGoodwill2022-04-012023-03-3105737737ns6:IntangibleAssetsOtherThanGoodwill2022-04-012023-03-3105737737ns6:PlantMachinery2022-04-012023-03-3105737737ns6:NetGoodwill2022-03-3105737737ns6:NetGoodwill2023-03-3105737737ns6:NetGoodwill2022-03-3105737737ns6:PlantMachinery2022-03-3105737737ns6:ComputerEquipment2022-03-3105737737ns6:ComputerEquipment2022-04-012023-03-3105737737ns6:PlantMachinery2023-03-3105737737ns6:ComputerEquipment2023-03-3105737737ns6:PlantMachinery2022-03-3105737737ns6:ComputerEquipment2022-03-3105737737ns6:WithinOneYearns6:CurrentFinancialInstruments2023-03-3105737737ns6:WithinOneYearns6:CurrentFinancialInstruments2022-03-3105737737ns6:RetainedEarningsAccumulatedLosses2022-03-3105737737ns6:RetainedEarningsAccumulatedLosses2022-04-012023-03-31
REGISTERED NUMBER: 05737737 (England and Wales)
























Unaudited Financial Statements

for the Year Ended 31 March 2023

for

Mobec Pharmacy Limited

Mobec Pharmacy Limited (Registered number: 05737737)






Contents of the Financial Statements
for the Year Ended 31 March 2023




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


Mobec Pharmacy Limited

Company Information
for the Year Ended 31 March 2023







Directors: M Nazemi
Miss R Innocent





Secretary: M Nazemi





Registered office: 2A Victoria Buildings
High Street
Abercarn
Newport
Gwent
NP11 5GT





Registered number: 05737737 (England and Wales)





Accountants: Curtis Bowden & Thomas Limited
Chartered Certified Accountants
101 Dunraven Street
Tonypandy
CF40 1AR

Mobec Pharmacy Limited (Registered number: 05737737)

Balance Sheet
31 March 2023

31.3.23 31.3.22
Notes £    £    £    £   
Fixed assets
Intangible assets 4 - -
Tangible assets 5 145 194
145 194

Current assets
Stocks 14,295 23,438
Debtors 6 223,499 206,715
Cash at bank and in hand 40,904 26,937
278,698 257,090
Creditors
Amounts falling due within one year 7 121,233 103,777
Net current assets 157,465 153,313
Total assets less current liabilities 157,610 153,507

Creditors
Amounts falling due after more than one
year

8

(25,978

)

(36,694

)

Accruals and deferred income (41,377 ) (40,166 )
Net assets 90,255 76,647

Capital and reserves
Called up share capital 2 2
Retained earnings 9 90,253 76,645
Shareholders' funds 90,255 76,647

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Mobec Pharmacy Limited (Registered number: 05737737)

Balance Sheet - continued
31 March 2023


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 6 October 2023 and were signed on its behalf by:





M Nazemi - Director


Mobec Pharmacy Limited (Registered number: 05737737)

Notes to the Financial Statements
for the Year Ended 31 March 2023

1. Statutory information

Mobec Pharmacy Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. Accounting policies

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 2006, is being amortised evenly over its estimated useful life of ten years.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery - 25% on reducing balance

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. Employees and directors

The average number of employees during the year was 6 (2022 - 5 ) .

Mobec Pharmacy Limited (Registered number: 05737737)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2023

4. Intangible fixed assets
Goodwill
£   
Cost
At 1 April 2022
and 31 March 2023 200,000
Amortisation
At 1 April 2022
and 31 March 2023 200,000
Net book value
At 31 March 2023 -
At 31 March 2022 -

5. Tangible fixed assets
Plant and Computer
machinery equipment Totals
£    £    £   
Cost
At 1 April 2022
and 31 March 2023 831 10,700 11,531
Depreciation
At 1 April 2022 831 10,506 11,337
Charge for year - 49 49
At 31 March 2023 831 10,555 11,386
Net book value
At 31 March 2023 - 145 145
At 31 March 2022 - 194 194

6. Debtors: amounts falling due within one year
31.3.23 31.3.22
£    £   
Trade debtors 154,476 128,310
Other debtors 69,023 78,405
223,499 206,715

7. Creditors: amounts falling due within one year
31.3.23 31.3.22
£    £   
Bank loans and overdrafts 10,000 10,000
Trade creditors 101,127 84,617
Taxation and social security 6,913 6,203
Other creditors 3,193 2,957
121,233 103,777

Mobec Pharmacy Limited (Registered number: 05737737)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2023

8. Creditors: amounts falling due after more than one year
31.3.23 31.3.22
£    £   
Bank loans 25,978 36,694

9. Reserves
Retained
earnings
£   

At 1 April 2022 76,645
Profit for the year 19,608
Dividends (6,000 )
At 31 March 2023 90,253

10. Directors' advances, credits and guarantees

As at 31 March 2023 Dr M Nazemi, a director, owed the company £22,980. There was a aggregate of advances of £nil and credits of £nil.

As at 31 March 2023 Miss R Innocent,a director, owed the company £11,507. There was an aggregate of advances of £10,950 and credits of £13,700.

These amounts are interest free and payable within one year.

11. Ultimate controlling party

The company is controlled by its directors,who own 100% of the issued share capital.